Assessment ofOPG/RANK/RANKLGene Expression Levels in Peripheral Blood Mononuclear Cells (PBMC) After Treatment With Strontium Ranelate and Ibandronate in Patients With Postmenopausal Osteoporosis | Zendy

Michał Stuss | Zendy; Piotr Rieske | Zendy; Agnieszka Cegłowska | Zendy; Wioletta Stępień-Kłos | Zendy; Paweł P. Liberski | Zendy; Ewa BrzeziańskaLasota | Zendy; Ewa Sewerynek | Zendy

Open Access

Assessment ofOPG/RANK/RANKLGene Expression Levels in Peripheral Blood Mononuclear Cells (PBMC) After Treatment With Strontium Ranelate and Ibandronate in Patients With Postmenopausal Osteoporosis

Author(s) -

Michał Stuss,

Piotr Rieske,

Agnieszka Cegłowska,

Wioletta Stępień-Kłos,

Paweł P. Liberski,

Ewa BrzeziańskaLasota,

Ewa Sewerynek

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-3885

Subject(s) - medicine , peripheral blood mononuclear cell , strontium ranelate , rankl , osteoporosis , parathyroid hormone , bone remodeling , bone mineral , osteoprotegerin , vitamin d and neurology , endocrinology , postmenopausal osteoporosis , gastroenterology , calcium , receptor , biology , activator (genetics) , biochemistry , in vitro

Recent research results have confirmed the high significance of the OPG/RANK/RANKL system in the development of bone diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research